arrow
E

Eishin Morita

medicine
H指数:47
被引数:7,673

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improvement of the Ocular Prognosis of Epidermal Necrolysis: A National Survey in Japan
2024-11-011
OAAI
Association of HLA-A*11:01, HLA-B*39:01, and HLA-B*56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions
2024-05-012
PRE
Differential Effects of HLA-B*15:11 and HLA-A*31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions
2024-04-014
PRE
Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN

开发和验证预测stevens-johnson综合征和中毒性表皮坏死松解症死亡率的新评分: CRISTEN

2023-10-018
OAAI
Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)
2022-12-165
PRE
Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients
2022-08-017
PRE
Genome-wide association study reveals an association between the HLA-DPB1*02:01:02 allele and wheat-dependent exercise-induced anaphylaxis
2021-08-0118
OAAI
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial

口服berotralstat预防日本患者遗传性血管性水肿发作: 一项3期随机试验

2020-12-2330
OAAI
The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018
2020-12-0138
PREAI
Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients
2020-08-0122
OAAI